Compare WHD & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHD | MMED |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | 2800 |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.3B |
| IPO Year | 2018 | 2026 |
| Metric | WHD | MMED |
|---|---|---|
| Price | $55.12 | $16.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $56.33 | $22.56 |
| AVG Volume (30 Days) | 795.2K | ★ 1.2M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | ★ 18.99 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $1,079,051,000.00 | N/A |
| Revenue This Year | $43.92 | $15.99 |
| Revenue Next Year | $6.83 | $10.00 |
| P/E Ratio | $291.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.30 | $10.65 |
| 52 Week High | $64.30 | $17.86 |
| Indicator | WHD | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 63.33 |
| Support Level | $52.51 | $14.70 |
| Resistance Level | $58.53 | N/A |
| Average True Range (ATR) | 1.52 | 0.90 |
| MACD | 0.53 | 0.04 |
| Stochastic Oscillator | 81.10 | 73.31 |
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.